HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs)

Heart Rhythm

Volumn 5, Issue 6, 2008, Pages 907-925

  Wilkoff, Bruce L ^a   Auricchio, Angelo ^b   Brugada, Josep ^c   Cowie, Martin ^d   Ellenbogen, Kenneth A ^e   Gillis, Anne M ^f   Hayes, David L ^g   Howlett, Jonathan G ^h   Kautzner, Josef ⁱ   Love, Charles J ^j   Morgan, John M ^k   Priori, Silvia G ^l   Reynolds, Dwight W ^m   Schoenfeld, Mark H ⁿ   Vardas, Panos E ^o  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DIVISION OF CARDIOLOGY   (Switzerland)

^c UNIVERSITY OF BARCELONA   (Spain)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

^g MAYO CLINIC   (United States)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^j OHIO STATE UNIVERSITY   (United States)

^k Corner Cottage ^*  (United Kingdom)

^l UNIVERSITY OF PAVIA   (Italy)

^m UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

ⁿ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; CONSENSUS DEVELOPMENT; DEFIBRILLATOR; EQUIPMENT DESIGN; FOLLOW UP; GOVERNMENT REGULATION; HEART ARRHYTHMIA; HEART FAILURE; HOLTER MONITORING; HOME MONITORING; HUMAN; IMPLANT REGISTRY; IMPLANTATION; INFORMATION PROCESSING; LEGAL ASPECT; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL SOCIETY; PARAMEDICAL PERSONNEL; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; SAFETY; SURVIVAL RATE; TELECONSULTATION; TELEMETRY; TREATMENT INDICATION; TREATMENT WITHDRAWAL;

AMERICAN HEART ASSOCIATION; CONSENSUS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EUROPE; HEART FAILURE; HUMANS; MONITORING, PHYSIOLOGIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 44649131262     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.04.013     Document Type: Article

References (61)

1. Source: EUCOMED (European Medical Technology Industry Association) unpublished data, website at: http://www.eucomed.be/
2. Hayes D.L., Naccarelli G.V., Furman S., Parsonnet V., Reynolds D., Goldschlager N., Gillette P., Maloney J.D., Saxon L., Leon A., Daoud E., and North American Society of Pacing and Electrophysiology. NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol 26 7 Pt 1 (2003) 1556-1562
3. Nacarelli G.V., Conti J.B., DiMarco J.P., and Tracy C.M. 2008 COCATS 3 Task Force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management. Heart Rhythm 5 (2008) 332-337
4. Hayes J.J., Juknavorian R., and Maloney J.D. North American Society of Pacing and Electrophysiology (NASPE) Policy Statement: the role(s) of the industry employed allied professional. Pacing Clin Electrophysiol 24 (2001) 398-399
5. Love C.J. Pacemaker troubleshooting and follow-up. In: Ellenbogen K.A., Kay G.N., Lau C.-P., and Wilkiff B.L. (Eds). Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Third edition (2007), Saunders Elsevier, Philadelphia Chapter 24
6. Fraser J.D., Gillis A.M., Irwin M.E., Nishimura S., Tyers G.F., Philippon F., and Canadian Working Group on Cardiac Pacing. Guidelines for pacemaker follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. Can J Cardiol 16 (2000) 355-363
7. Gillis A.M., Philippon F., Cassidy M.R., Singh N., Dorian P., Love B.A., Kerr C.R., and Canadian Working Group on Cardiac Pacing. Guidelines for implantable cardioverter-defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. Can J Cardiol 19 (2003) 21-37
8. Winters S.L., Packer D.L., Marchlinski F.E., Lazzara R., Cannom D.S., Breithardt G.E., Wilber D.A., Camm A.J., Ruskin J.N., and North American Society of Electrophysiology and Pacing. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter-defibrillators. North American Society of Electrophysiology and Pacing. Pacing Clin Electrophysiol 24 (2001) 262-269
9. Joseph G.K., Wilkoff B.L., Dresing T., Burkhardt J., and Khaykin Y. Remote interrogation and monitoring of implantable cardioverter-defibrillators. J Interv Card Electrophysiol 11 (2004) 161-166
10. Schoenfeld M.H., Compton S.J., Mead R.H., Weiss D.N., Sherfesee L., Englund J., and Mongeon L.R. Remote monitoring of implantable cardioverter-defibrillators: a prospective analysis. Pacing Clin Electrophysiol 27 (2004) 757-763
11. Schoenfeld M.H., and Reynolds D.W. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol 28 (2005) 235-240
12. Brugada P. What evidence do we have to replace in-hospital implantable cardioverter-defibrillator follow-up?. Clin Res Cardiol 95 Suppl 3 (2006) III3-III9
13. Saxon L.A., Boehmer J.P., Neuman S., and Mullin C.M. Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale. J Card Fail 13 (2007) 241-246
14. Schoenfeld M.H., and Reynolds D.W. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol 28 (2005) 235-240
15. Joseph G.K., Wilkoff B.L., Dresing T., Burkhardt J., and Khaykin Y. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol 11 (2004) 161-166
16. Fauchier L., Sadoul N., Kouakam C., Briand F., Chauvin M., Babuty D., and Clementy J. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 28 Suppl I (2005) S255-S259
17. Ellery S., Pakrashi T., Paul V., and Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring-the Home CARE pilot study. Clin Res Cardiol 95 Suppl 3 (2006) III29-III35
18. Ricci R.P., Russo M., and Santini M. Management of atrial fibrillation-what are the possibilities of early detection with home monitoring?. Clin Res Cardiol 95 Suppl 3 (2006) III10-III16
19. Res J.C., Theuns D.A., and Jordaens L. The role of remote monitoring in the reduction of inappropriate implantable cardioverter-defibrillator therapies. Clin Res Cardiol 95 Suppl 3 (2006) III17-III21
20. Furman S. Safe Medical Devices Act of 1990. Pacing Clin Electrophysiol 14 (1991) 387-388
21. Anselmann N. The European legislation on medical devices. Stud Health Technol Inform 28 (1996) 5-12
22. Buxton A.E., Calkins H., Callans D.J., DiMarco J.P., et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures. J Am Coll Cardiol 48 (2006) 2360-2396
23. Carlson M.D., Wilkoff B.L., Maisel W.H., Ellenbogen K.A., et al. Recommendations from the Heart Rhythm Society on Device Performance Policies and Guidelines. Heart Rhythm 3 (2006) 1250-1273
24. Auricchio A., Gropp M., Ludgate S., Vardas P., Brugada J., and Priori S.G. European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance. Europace 8 (2006) 313-322
25. Sorel S. Medical Device Development: U.S. and EU Differences. Applied Clinical Trials. http://actmagazine.findpharma.com/appliedclinicaltrials/article/articleD etail.jsp?id=363640
26. Council Directive 90/385/EEC of 20 June 1990. http://europa.eu.int/comm/enterprise/medical_devices/legislation_en.htm
27. Medical Device Reporting. http://www.fda.gov/CDRH/DEVADVICE/351.html
28. MEDDEV 2.12/1. Guidelines on a Medical Devices Vigilance System. http://www.mdss.com/MDEV/meddev2-12.htm
29. Guidance for Industry-Medical Device Tracking. http://www.fda.gov/cdrh/comp/guidance/169.html
30. Hammill S.C., Stevenson L.W., Kadish A.H., Kremers M.S., Heidenreich P., Lindsay B.D., et al. National ICD Registry Annual Report 2006 Review of the registry's first year, data collected, and future plans. Heart Rhythm 4 (2007) 1260-1263
31. Hayes D.L., Naccarelli G.V., Furman S., Parsonnet V., Reynolds D., Goldschlager N., Gillette P., Maloney J.D., Saxon L., Leon A., Daoud E., and North American Society of Pacing and Electrophysiology. NASPE (HRS) training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol 26 7 Pt I (2003) 1556-1562
32. Tibi T., Moceri P., Martin Teule C., Berkane N., Talbodec A., Tannous J., and Zemour G. Local registry of pacemakers implantations: proposals to decrease the infectious risk. Ann Cardiol Angeiol 55 (2006) 339-341 (Paris)
33. Bonhorst D., de Sousa J., and Adragao P. National Registry on Cardiac Electrophysiology-2004. Rev Port Cardiol 25 (2006) 353-361
34. Silveira M.J., DiPiero A., Gerrity M.S., and Feudtner C. Patients' knowledge of options at the end of life: ignorance in the face of death. JAMA 284 (2000) 2483-2488
35. Meisel A., Snyder L., and Quill T. Seven legal barriers to end-of-life care: myths, realities, and grains of truth. JAMA 284 (2000) 2495-2501
36. Miller F.G., Fins J.J., and Snyder L. Assisted suicide compared with refusal of treatment: a valid distinction?. University of Pennsylvania Center for Bioethics Assisted Suicide Consensus Panel. Ann Intern Med 132 (2000) 470-475
37. Lewis W.R., Luebke D.L., Johnson N.J., et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 119 (2006) 892-896
38. Goldstein N.E., Lampert R., Bradley E., et al. Management of implantable cardioverter-defibrillators in end-of-life care. Ann Intern Med 141 (2004) 835-838
39. Braun T.C., Hagen N.A., Hatfield R.E., and Wyse D.G. Cardiac pacemakers and implantable defibrillators in terminal care. J Pain Symptom Manage 18 (1999) 126-131
40. Berger J.T. The ethics of deactivating implanted cardioverter-defibrillators. Ann Intern Med 142 (2005) 631-634
41. Iskos D., Lurie K.G., Sakaguchi S., and Benditt D.G. Termination of implantable pacemaker therapy: experience in five patients. Ann Intern Med 126 (1997) 787-790
42. Schoenfeld M.H. Deciding against defibrillator replacement: second-guessing the past?. Pacing Clin Electrophysiol 23 (2000) 2019-2021
43. Gostin L.O. Deciding life and death in the courtroom. From Quinlan to Cruzan, Glucksberg, and Vacco-a brief history and analysis of constitutional protection of the "right to die.". JAMA 278 (1997) ):1523-8
44. Cancer pain relief and palliative care (1990), Technical Report Series 804 World Health Organization, Geneva 11-12
45. Berger J.T. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 142 (2005) 631-634
46. Schneiderman L.J., Kaplan R.M., Pearlman R.A., and Teetzel H. Do physicians' own preferences for life-sustaining treatment influence their perceptions of patients' preferences?. J Clin Ethics 4 (1993) 28-33
47. Uhlmann R.F., and Pearlman R.A. Perceived quality of life and preferences for life-sustaining treatment in older adults. Arch Intern Med 151 (1991) 495-497
48. Schneiderman L.J., Kaplan R.M., Rosenberg E., and Teetzel H. Do physicians' own preferences for life-sustaining treatment influence their perceptions of patients' preferences?. A second look. Camb Q Healthc Ethics 6 (1997) 131-137
49. Colorado Hospice Organization Position Paper: Cardiac Pacing Devices. March 2007.
50. Furrow B., Greaney T., Johnson H., Jost T., and Schwartz R. Bioethics health care law and ethics. Life and Death Decisions: Principles of Autonomy and Beneficence (2001), West Group, St. Paul, MN 246-263
51. Kobza R., and Erne P. End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol 30 (2007) 845-849
52. England R., Egland T., and Coggon J. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics 33 (2007) 538-540
53. Council on Ethical and Judicial Affairs, American Medical Association. Guidelines for the appropriate use of do-not-resuscitate orders. JAMA 265 (1991) 1868-1871
54. Lewis W.R., Luebke D.L., Johnson N.J., et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 119 (2006) 892-896
55. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 8 (2006) 746-837
56. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Heart Rhythm 5 (2008)
57. Crowley G. EU and US clinical investigation adverse event reporting. Med Device Technol 15 (2004) 30-32
58. Donawa M. Medical device directive: preparing for the amendments. Med Device Technol 11 (2000) 40-45
59. Beholz S., Koch C., and Konertz W. Quality management system of a university cardiac surgery department according to DIN EN ISO 9001: 2000. Thorac Cardiovasc Surg 51 (2003) 167-173
60. Donawa M. Update on ISO 13485. Med Device Technol 13 (2002) 23-25
61. ISO 13485:2003, International Organization for Standardization.